Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRVI | AZN | AMGN | GILD | VRTX |
| Company | Trevi Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 17.48 | 184.82 | 350.06 | 125.27 | 475.11 |
| High | 18.12 | 186.58 | 359.10 | 126.95 | 486.49 |
| Low | 17.33 | 184.55 | 350.06 | 123.91 | 473.50 |
| Latest | 17.99 | 185.71 | 355.13 | 124.59 | 479.84 |
| Change | +0.47 | +2.69 | +3.70 | -0.57 | +4.64 |
| % Change | +2.68% | +1.47% | +1.05% | -0.46% | +0.98% |
| Volume | 3,014,579 | 1,480,358 | 1,119,249 | 4,208,952 | 887,901 |
| 20-Day Average Volume | 1,692,318 | 1,953,787 | 3,077,100 | 9,069,658 | 1,418,914 |
| Previous Close | 17.52 | 183.02 | 351.43 | 125.16 | 475.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.95 | 180.59 | 343.84 | 127.17 | 449.85 |
| 20-Day Raw Stochastic | 92.04% | 87.62% | 87.70% | 18.66% | 93.33% |
| 20-Day Relative Strength | 70.62 | 52.04 | 56.80 | 41.64 | 65.10 |
| Weighted Alpha | +199.16 | +24.82 | +24.81 | +6.31 | +14.52 |
| Today's Opinion | 100% Buy | 24% Sell | 56% Buy | 72% Sell | 40% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 40% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | 96% Buy | 8% Buy | 8% Sell | 8% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.52% since 06/17/26 | +4.24% since 06/17/26 | +3.78% since 06/17/26 | -0.88% since 06/17/26 | +5.02% since 06/17/26 |
| Low | 16.48 on 06/18/26 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 450.39 on 06/18/26 |
| High | 18.16 on 06/23/26 | 186.53 on 06/25/26 | 359.10 on 06/25/26 | 127.27 on 06/24/26 | 486.48 on 06/25/26 |
| 1-Month | |||||
| %Chg | +25.73% since 05/22/26 | -0.85% since 05/22/26 | +4.50% since 05/22/26 | -7.46% since 05/22/26 | +10.94% since 05/22/26 |
| Low | 13.20 on 06/09/26 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 18.16 on 06/23/26 | 188.72 on 05/27/26 | 359.10 on 06/25/26 | 137.20 on 05/29/26 | 486.48 on 06/25/26 |
| 3-Month | |||||
| %Chg | +55.29% since 03/25/26 | -0.91% since 03/25/26 | +0.18% since 03/25/26 | -10.07% since 03/25/26 | +5.95% since 03/25/26 |
| Low | 10.95 on 03/30/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 18.16 on 06/23/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 486.48 on 06/25/26 |
| 6-Month | |||||
| %Chg | +36.97% since 12/24/25 | +0.29% since 12/24/25 | +6.17% since 12/24/25 | -1.06% since 12/24/25 | +4.12% since 12/24/25 |
| Low | 9.82 on 02/19/26 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 18.16 on 06/23/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,487,490 | 283,847,168 | 189,669,584 | 155,394,896 | 120,608,144 |
| Shares Outstanding, K | 141,980 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -42,760,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -13,190,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.04 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 05/05/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/06/26 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.55 | 15.70 | 14.94 | 27.85 |